Surgical Innovations Group plc (SUN:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Surgical Innovations Group plc stock forecast from 0 analysts, the average analyst target price for Surgical Innovations Group plc is not available over the next 12 months. Surgical Innovations Group plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Surgical Innovations Group plc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Surgical Innovations Group plc’s stock price was GBX 0.5. Surgical Innovations Group plc’s stock price has changed by +0.00% over the past week, -9.09% over the past month and -74.36% over the last year.
No recent analyst target price found for Surgical Innovations Group plc
No recent average analyst rating found for Surgical Innovations Group plc
Company Overview Surgical Innovations Group plc
Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite and YelloPort +plus port access systems; PretzelFlex, a surgical retracting system; FastClamp, an endoscopic clamping system; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic instrument; and LogiFlex, an articulating dissector and retractor. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom. Read Less
Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It o...Read More
Frequently Asked Questions About Surgical Innovations Group plc (SUN:LSE) Stock
Stock Target Advisor's fundamental analysis for Surgical Innovations Group plc's stock is Neutral.
Unfortunately we do not have enough data on SUN:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SUN:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on SUN:LSE's stock to indicate if its overvalued.
The last closing price of SUN:LSE's stock was GBX 0.50.
The most recent market capitalization for SUN:LSE is GBX 4.66M.
Unfortunately we do not have enough analyst data on SUN:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Surgical Innovations Group plc's stock.
As per our most recent records Surgical Innovations Group plc has 100 Employees.
Surgical Innovations Group plc's registered address is Clayton Wood House, Leeds, United Kingdom, LS16 6QZ.
You can get more information about it from Surgical Innovations Group plc's website at https://www.sigroupplc.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SUN:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
